Divi's Labs Vishakhapatnam plant completes inspection

Image
Press Trust of India New Delhi
Last Updated : Aug 04 2017 | 3:32 PM IST
Drug firm Divi's Laboratories today said its Vishakhapatnam facility has successfully completed inspection by the health products regulators of Ireland and Slovenia without any critical observations.
In a regulatory filing to the BSE, Divi's Laboratories said the company's Unit-2 at Vishakhapatnam has been inspected by five inspectors from Health Products Regulatory Authority (HPRA) of Ireland and Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) of Slovenia from July 31 to August 4, 2017.
The inspection was focused on follow up on the effectiveness of the corrective and preventive actions (CAPA's) implemented from the last JAZMP inspection, it added.
The inspectors also focused on the general GMP inspection of the site, Divi's Laboratories said.
"The inspection has concluded successfully with no critical observations", it added.
Shares of Divi's Laboratories were today trading at Rs 680.10 per scrip in the afternoon trade on BSE, up 1.44 per cent from its previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 04 2017 | 3:32 PM IST

Next Story